Exploratory Clinical Development World is nearly here: We only have two weeks left until the event takes place.
You would be joining some of the world’s best pharmaceutical companies. Those attending so far include:
Abbott, Actelion Pharmaceuticals, Aderans Research Institute, Aptiv Solutions, AstraZeneca, AstraZeneca R&D, Bayer Healthcare, Bayer Pharma AG , Bayer Technology Services GmbH, Biocartis SA, BioMartin Pharmaceutical, Bristol Myers Squibb, Cancer Research UK, Celgene, Chiesi Farmaceutici, Clinical Reference Laboratory, Daiichi Sankyo Pharma, Debiopharm SA, DUCK FLATS Pharma, Eisai, Eli Lilly, European Commission, Everest Biotech, F. Hoffmann- La Roche, Federal Agency for Medicines and Health Products, Galapagos Research Center, Gilead Sciences, GlaxoSmithKline, GlaxoSmithKline R&D, Hoffmann-La Roche, Industrial Technology Research Institute, J&J Pharmaceutical R&D, Janssen Pharmaceuticals, Java Clinical Research, Johnson & Johnson, Leo Pharma, London Genetics, MedImmune, Merck, Merck Research Laboratories, Merck Serono SA, Merck Sharp & Dohme Europe, Novartis, Novartis Institutes for BioMedical Research, Novartis Pharmaceutical R&D, Nuvisan GmbH, Nycomed, Orion Corporation, Oxford Biodynamics, Pfizer, Quality Assistance, Roche China, Roche/Genentech, Sanofi R&D, Sanofi-Aventis R&D, Selcia, Selventa, Shire Pharmaceuticals, Sunovian Pharmaceuticals, Takeda Pharmaceuticals, Technology Strategy Board, Telormedix SA, UCB Pharma S.A, UCD Conway Institute of Biomolecular & Biomedical Research and more.
Make sure your register nowÂ to ensure you hear the latest clinical development strategies in phase I from the industry’s best experts.